JPRN-jRCT2080223480未知2 期
Phase 2a exploratory, randomized, double-blind, parallel-group study of ONO-8577 compared to combination of solifenacin succinate/ mirabegron for overactive bladder
ONO PHARMACEUTICAL CO.,LTD.0 个研究点目标入组 200 人开始时间: 2017年3月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •1. Sexes: Both
- •2. Ages: 20 years to 80 years
- •3. Patient with symptoms of overactive bladder for >=6 months
排除标准
- •1. Patient with genuine stress incontinence, or with stress-predominant mixed urinary incontinence
- •2. Patient who has never experienced urge urinary incontinence during disease duration of overactive bladder
研究者
相似试验
进行中（未招募）
1 期
A study to evaluate the effectiveness and safety of study drug (sepranolone) in women with menstrual migraineMenstrual migraineEUCTR2019-001081-15-FIAsarina Pharma ApS84
进行中（未招募）
1 期
A study to evaluate the effectiveness and safety of study drug (sepranolone) in women with menstrual migraineMenstrual migraineEUCTR2019-001081-15-SEAsarina Pharma ApS84
进行中（未招募）
1 期
An exploratory Phase 2, randomized, double-blind, placebo-controlled, parallel design study to evaluate the safety, tolerability, and pharmacodynamics of AZD1722 in CKD patients with type 2 diabetes mellitus and albuminuriaChronic kidney disease (CKD) with type 2 diabetes mellitus and albuminuriaMedDRA version: 17.0Level: LLTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 100000004857EUCTR2013-005345-36-DEArdelyx, Inc.140
进行中（未招募）
1 期
A Safety and Efficacy Study of GWP42003-P (Cannabidiol; CBD) in Children and Young Adults with Autism Spectrum Disorder.Autism Spectrum Disorder (ASD)MedDRA version: 21.1Level: PTClassification code 10063844Term: Autism spectrum disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2020-002819-21-DEGW Research Ltd103
进行中（未招募）
1 期
A Safety and Efficacy Study of GWP42003-P (Cannabidiol; CBD) in Children and Young Adults with Autism Spectrum Disorder.Autism Spectrum Disorder (ASD)MedDRA version: 21.1Level: PTClassification code 10063844Term: Autism spectrum disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2020-002819-21-ESGW Research Ltd160